TG

Tripti Gururani

Active Director Director DIN 09617482
DIN 09617482 First appointment May 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Tripti Gururani

Data last updated:

Tripti Gururani is a Director at Noise2 Pharma Private Limited (since 2022). The company operates in Chemicals. Noise2 Pharma Private Limited reported revenue of ₹11.7 Lakh (FY 2024).

DIN 09617482
Primary Designation Director
Industry Chemicals
First Appointment 24 May 2022
Oldest Company Age 4 yrs
Largest company Noise2 Pharma Private Limited · ₹11.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Noise2 Pharma Private Limited U24110UP2022PTC164688
Director24 May 20222022₹11.7 Lakh (FY 2024)Active

Board colleagues of Tripti Gururani

NameDINCompanyDesignation
Neetu Sharma09617481Noise2 Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Noise2 Pharma Private Limited
Premium access

Shareholding and investment profile for Tripti Gururani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tripti Gururani

Tripti Gururani currently holds 1 directorship: Noise2 Pharma Private Limited (Director, since 24 May 2022, revenue ₹11.7 Lakh (FY 2024)).

Tripti Gururani was first appointed on 24 May 2022 as Director at Noise2 Pharma Private Limited.

The current boards of Tripti Gururani's companies include Neetu Sharma (Noise2 Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available